SERPINA1 and asthma: Our results indicate that although there were significant differences in serum AAT levels between the PI*SS and PI*SZ genotypes, there were no significant differences in clinical manifestations, i.e. the prevalence of emphysema, COPD, asthma, bronchiectasis, or differences in lung function or quality of life, after careful matching for confounders.